Author

Stephanie Dille

Observed name: S. Dille

Institution: Iomedico (Germany)

Observed institution: Iomedico (Germany)

ORCID: 0000-0001-9465-8345

Observed ORCID: 0000-0001-9465-8345

OpenAlex ID: A5063139499

Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer

2020 · Norbert Marschner, Stefan Zacharias, et al. · JAMA Network Open · 92

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

2021 · Martin Sebastian, Wilfried E.E. Eberhardt, et al. · Lung Cancer · 83

Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line – Results from the prospective German TLK cohort study

2019 · Claus-Christoph Steffens, Corinna Elender, et al. · Lung Cancer · 52

Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms

2018 · and the TLN-Group (Tumour Registry Lymphatic Neoplasms), Wolfgang Knauf, et al. · Annals of Hematology · 34

Head‐to‐head comparison of palbociclib and ribociclib in first‐line treatment of HR ‐positive/ HER2 ‐negative metastatic breast cancer with real‐world data from the OPAL registry

2024 · Marc Thill, Mark‐Oliver Zahn, et al. · International Journal of Cancer · 26

Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project

2019 · The TMK-Group (Tumour Registry Breast Cancer), Norbert Marschner, et al. · Breast Cancer Research and Treatment · 26

Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO

2020 · Karin Potthoff, Oliver Stötzer, et al. · Clinical Breast Cancer · 4

Corrigendum to “Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line – Results from the prospective German TLK cohort study” [Lung Cancer 130 (2019) (April) 216–225]

2019 · Claus-Christoph Steffens, Corinna Elender, et al. · Lung Cancer · 2

Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care

2026 · L. Sellmann, D. Marschner, et al. · ESMO Real World Data and Digital Oncology · 1

Prospective, longitudinal oncology registries enabling advanced real-world evidence: the iOMEDICO experience

2026 · M. Jänicke, S. Dille, et al. · ESMO Real World Data and Digital Oncology

Works count: 10

Citation count: 320

H-index: 6

I10-index: 6